Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beigene | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥241.50B | -61.7x | -1.45 | CN¥250.08 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.1% Upside | Upgrade to Pro+ | |
WuXi AppTec | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥185.63B | 17.1x | -0.88 | CN¥64.90 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31.1% Upside | Upgrade to Pro+ | |
Hangzhou Tigermed Consulting | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥45.29B | 135.8x | -1.49 | CN¥52.96 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.6% Upside | Upgrade to Pro+ | |
Pharmaron Beijing | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥44.58B | 23.8x | 0.8 | CN¥25.18 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.4% Upside | Upgrade to Pro+ | |
Shanghai Allist Pharmaceuticals Co | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥43.20B | 0.42 | CN¥94.97 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.1% Upside | Upgrade to Pro+ | ||
RemeGen | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥30.36B | -16.5x | -1.97 | CN¥63 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -22% Downside | Upgrade to Pro+ | |
Dizal Jiangsu Pharmaceutical | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥29.41B | -28.5x | -1.28 | CN¥63.58 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.3% Upside | Upgrade to Pro+ | |
InnoCare Pharma | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥25.19B | -57.9x | -3.01 | CN¥26.40 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sinocelltech Group | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥21.11B | 172.9x | 1.12 | CN¥46.99 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 36.3% Upside | Upgrade to Pro+ | |
BGI Genomics | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥19.87B | -22.3x | 0.01 | CN¥52.11 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.5% Upside | Upgrade to Pro+ | |
InventisBio | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥18.97B | -54.2x | -6.26 | CN¥34.20 | 4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -7.5% Downside | Upgrade to Pro+ | |
Joinn Laboratories China | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥14.65B | 39x | 0.05 | CN¥19.83 | 3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -9.7% Downside | Upgrade to Pro+ | |
Bio-Thera Solutions | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥11.34B | -18.3x | 0.74 | CN¥28.58 | 4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.8% Upside | Upgrade to Pro+ | |
Mabwell Shanghai Bioscience | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥11.15B | -7.1x | 0.76 | CN¥29.30 | 5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sino Biological | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥7.85B | 75.6x | -1.43 | CN¥65.22 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.6% Upside | Upgrade to Pro+ | |
HitGen | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥6.89B | 97.6x | 10.38 | CN¥17.16 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -6.9% Downside | Upgrade to Pro+ | |
Shouyao Holdings Beijing | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥6.40B | -24.3x | 2.94 | CN¥41.91 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.2% Upside | Upgrade to Pro+ | |
Beijing Sun Novo Pharmaceutical Research | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥6.09B | 45.3x | -1.25 | CN¥54.42 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ChemPartner PharmaTech | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥5.83B | -32.5x | -0.33 | CN¥11.70 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hinova Pharmaceuticals | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥5.68B | -23.7x | -0.87 | CN¥57.52 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.7% Upside | Upgrade to Pro+ | |
Jiangsu Asieris Pharmaceuticals | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥5.30B | -13.1x | -1.56 | CN¥9.43 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.5% Upside | Upgrade to Pro+ | |
GemPharmatech | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥5.25B | 46.8x | -1.59 | CN¥12.76 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.3% Upside | Upgrade to Pro+ | |
Hangzhou BioSincerity PharmaTech | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥4.95B | -29.3x | 0.23 | CN¥45.02 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
R G PharmaStudies | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥4.88B | 30.5x | -1.29 | CN¥51.85 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.8% Upside | Upgrade to Pro+ | |
Shanghai Medicilon | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥4.69B | -14x | 0.02 | CN¥34.99 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Beijing Kawin Technology Shareholding Co | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥4.68B | 31.1x | 2.06 | CN¥27.99 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 43% Upside | Upgrade to Pro+ | |
PharmaResources Shanghai | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥4.66B | 183.2x | -18.43 | CN¥34.13 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shanghai Aladdin Biochemical Technology Co | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥4.10B | 37.3x | 2.4 | CN¥12.23 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -7% Downside | Upgrade to Pro+ | |
Bide Pharmatech | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥4.06B | 30.5x | 1.23 | CN¥49.79 | 7.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.2% Upside | Upgrade to Pro+ | |
Guangzhou Boji Medical & Biotech | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥3.66B | 240.8x | -4.46 | CN¥9.63 | 3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Qingdao Vland Biotech | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥3.51B | 57.8x | -2.09 | CN¥13.88 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19% Upside | Upgrade to Pro+ | |
Xinjiang Baihuacun | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥3.04B | 72.1x | 1.33 | CN¥7.92 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Anhui Wanbang Pharmaceutical | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥3B | 37.1x | -0.85 | CN¥47.65 | 5.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |